Amurensin G, a potent natural SIRT1 inhibitor, rescues doxorubicin responsiveness via down-regulation of multidrug resistance 1 - Wikidata - wikimedia - TriplyDB

Amurensin G, a potent natural SIRT1 inhibitor, rescues doxorubicin responsiveness via down-regulation of multidrug resistance 1

Amurensin G, a potent natural SIRT1 inhibitor, rescues doxorubicin responsiveness via down-regulation of multidrug resistance 1

http://www.wikidata.org/entity/Q28290644

about

Emerging Roles of SIRT1 in Cancer Drug Resistance Rejuvenating sirtuins: the rise of a new family of cancer drug targets Expression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomas.The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet Harnessing quinone methides: total synthesis of (±)-vaticanol A.Activating transcription factor 4 confers a multidrug resistance phenotype to gastric cancer cells through transactivation of SIRT1 expression.Creation of an HDAC-based yeast screening method for evaluation of marine-derived actinomycetes: discovery of streptosetin A.Sorting out functions of sirtuins in cancer Sirtuin 1 facilitates chemoresistance of pancreatic cancer cells by regulating adaptive response to chemotherapy-induced stress Sensitization of chemo-resistant human chronic myeloid leukemia stem-like cells to Hsp90 inhibitor by SIRT1 inhibition.Janus-faced role of SIRT1 in tumorigenesis.Sensitization of multidrug-resistant human cancer cells to Hsp90 inhibitors by down-regulation of SIRT1.SIRT1 and Neural Cell Fate Determination.Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.Forkhead transcription factor FOXO1 inhibits nuclear factor-κB in gastric cancer.The forkhead transcription factor FOXO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase/Akt pathway.Amurensin G enhances the susceptibility to tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity of cancer stem-like cells of HCT-15 cells.Up-regulation of silent information regulator 2 (Sir2) is associated with amphotericin B resistance in clinical isolates of Leishmania donovani.The novel phloroglucinol PMT7 kills glycolytic cancer cells by blocking autophagy and sensitizing to nutrient stress.Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.Vitis amurensis Ruprecht root inhibited α-melanocyte stimulating hormone-induced melanogenesis in B16F10 cells.Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells.Gnetin-C and other resveratrol oligomers with cancer chemopreventive potential.SIRT1 promotes formation of breast cancer through modulating Akt activity.Regulations of P-Glycoprotein/ABCB1/MDR1 in Human Cancer Cells

P2860

Q28536892-45679CCE-F2AE-4AC2-A97B-E7BF70A1F9DD Q30570951-04400DE3-3FB8-42BE-A7FC-6D94D0A5929A Q31138148-B855287B-AF0E-4075-8E9C-EDDE1491E0B9 Q33566310-75576251-6B35-4403-AD79-F0FBDB4F38F6 Q33930027-008DBE25-74EC-4999-833C-48E5804818D5 Q34170941-E54708F5-7C54-4835-8D40-AB4995AA015C Q34483506-F87DD7E2-6C5F-4439-955F-8B17EADA5C59 Q34970771-29157515-8EFF-4F48-B914-4E60D52BC039 Q35051423-A3B11836-7953-47D8-B5B2-DB6FDA6073F1 Q35830047-D42DC6F5-1BD7-48FD-BF82-3EDF5F3F4876 Q36403645-F8DB2631-6BE9-4BC4-B964-4520792C5F50 Q36546609-4BCCAD01-9961-41BD-9C47-B9E7F4F260CD Q38409974-F21FEF87-21A9-45D8-93D3-6828BD87CFA1 Q38721759-C4D09DD8-63A7-4522-8D30-EB2EFD3F8FD0 Q38812000-F9CCCC48-FBB9-4DE1-AB6B-D22A575785DA Q39011214-A0092E76-6480-48A0-9F19-049BBA563A6F Q39066032-C697E6FD-8DA9-48E8-B013-6B497D2D2CDD Q39080597-31B87A3F-95BD-49F2-ACA5-348606670EBE Q39371673-970C41FF-DB5A-4ED4-9EA0-1733288E606B Q39571477-31F493C1-2766-4D75-8EAA-84F44026CF2C Q40425573-E347DBBF-B261-47F9-910B-A991ECE7F6AE Q41790657-6C137ACF-AE8D-41D8-A2ED-07A2E7A13979 Q48197662-2280D4AD-EB73-4BBB-B5B3-775ABFB6A8CF Q50254163-23EF5418-F21E-4F2F-B9BE-8C330FE49B37 Q55110307-15679CF5-3191-42B7-BAE6-51A8D9600D80 Q59072649-5067B236-8C6E-4B71-9BB9-FCA9F29EBBAD

P2860

Amurensin G, a potent natural SIRT1 inhibitor, rescues doxorubicin responsiveness via down-regulation of multidrug resistance 1

http://www.wikidata.org/entity/Q28290644

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Amurensin G, a potent natural ...... tion of multidrug resistance 1

@ast

Amurensin G, a potent natural ...... tion of multidrug resistance 1

@en

Amurensin G, a potent natural ...... tion of multidrug resistance 1

@nl

type

label

Amurensin G, a potent natural ...... tion of multidrug resistance 1

@ast

Amurensin G, a potent natural ...... tion of multidrug resistance 1

@en

Amurensin G, a potent natural ...... tion of multidrug resistance 1

@nl

prefLabel

Amurensin G, a potent natural ...... tion of multidrug resistance 1

@ast

Amurensin G, a potent natural ...... tion of multidrug resistance 1

@en

Amurensin G, a potent natural ...... tion of multidrug resistance 1

@nl

P1433

Q28290644-C9B03BFD-B364-458E-A51C-B0AF05A1AA8E

P1476

Q28290644-E50C989B-AC74-41B2-88A8-9F21867A0454

P2093

Q28290644-3C4C7895-7692-4529-8480-06080402F4F3

Q28290644-4B650023-96EC-4BDB-A97D-9B656466829D

Q28290644-4BCFF3C6-F589-4FC7-B544-4B1666DF8E7B

Q28290644-4D40FFC0-3659-4641-8C9D-2C60E06FAADC

Q28290644-52FB96D8-3589-4163-8FA0-17A2A457D714

Q28290644-63F393CA-DF9C-4155-9B42-82A4CCB511FB

Q28290644-8A017CA8-36C2-49FE-A066-6F0DEED4BF2B

Q28290644-919389A9-D51E-44E7-B7C3-D5DEBD142799

Q28290644-A4B7B38F-9F5E-4BFB-9754-35C3C9ECC469

Q28290644-A8A4CBA3-BFD2-4953-A659-960AD02BA17B

P304

Q28290644-77AFA439-3C79-4BA7-943A-D9C50DE07267

P31

Q28290644-B7EED62F-ED0B-41C8-BAE3-E7B9CBE05E09

P356

Q28290644-AE59CCC0-8E7F-4966-97C5-C7096F6A01C9

P407

Q28290644-B930CBD1-D2D5-44DA-8AE0-6D807B625FA6

P433

Q28290644-6FAB8C69-0DD0-441D-82AF-F564B4E97757

P478

Q28290644-377AFB6D-8777-46FF-8FB6-4277347BF26F

P50

Q28290644-55CF5304-78C5-4140-BC54-3233527C083B

P577

Q28290644-7F95BE70-78ED-4BF6-AF7F-D682E4BEE35B

P5875

Q28290644-865F2352-FAFD-4BC7-B355-FEECC0C23D18

P698

Q28290644-0E505C13-BC35-425E-B343-5C67B5A05C30

P921

Q28290644-D6697764-EE59-461F-8C95-4B416F41C337

P356

P1433

Molecular Pharmacology

P1476

Amurensin G, a potent natural ...... tion of multidrug resistance 1

@en

P2093

Hyo-Kyung Han

http://www.w3.org/2001/XMLSchema#string

Hyung Sik Kim

http://www.w3.org/2001/XMLSchema#string

Jung-Hoon Yoon

http://www.w3.org/2001/XMLSchema#string

Keon Wook Kang

http://www.w3.org/2001/XMLSchema#string

Kyoung Bin Cho

http://www.w3.org/2001/XMLSchema#string

Sang-Gun Ahn

http://www.w3.org/2001/XMLSchema#string

Seong-Min Kwon

http://www.w3.org/2001/XMLSchema#string

Tae Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Tae Hyung Kim

http://www.w3.org/2001/XMLSchema#string

Tran Thi Hien

http://www.w3.org/2001/XMLSchema#string

P304

855-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/MOL.110.065961

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45659865

http://www.w3.org/2001/XMLSchema#string

P698

20713551

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance